BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 16789841)

  • 1. Retroviral DNA integration: viral and cellular determinants of target-site selection.
    Lewinski MK; Yamashita M; Emerman M; Ciuffi A; Marshall H; Crawford G; Collins F; Shinn P; Leipzig J; Hannenhalli S; Berry CC; Ecker JR; Bushman FD
    PLoS Pathog; 2006 Jun; 2(6):e60. PubMed ID: 16789841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences.
    Mitchell RS; Beitzel BF; Schroder AR; Shinn P; Chen H; Berry CC; Ecker JR; Bushman FD
    PLoS Biol; 2004 Aug; 2(8):E234. PubMed ID: 15314653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses.
    Derse D; Crise B; Li Y; Princler G; Lum N; Stewart C; McGrath CF; Hughes SH; Munroe DJ; Wu X
    J Virol; 2007 Jun; 81(12):6731-41. PubMed ID: 17409138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factor binding sites are genetic determinants of retroviral integration in the human genome.
    Felice B; Cattoglio C; Cittaro D; Testa A; Miccio A; Ferrari G; Luzi L; Recchia A; Mavilio F
    PLoS One; 2009; 4(2):e4571. PubMed ID: 19238208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BET proteins promote efficient murine leukemia virus integration at transcription start sites.
    Sharma A; Larue RC; Plumb MR; Malani N; Male F; Slaughter A; Kessl JJ; Shkriabai N; Coward E; Aiyer SS; Green PL; Wu L; Roth MJ; Bushman FD; Kvaratskhelia M
    Proc Natl Acad Sci U S A; 2013 Jul; 110(29):12036-41. PubMed ID: 23818621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.
    Gupta SS; Maetzig T; Maertens GN; Sharif A; Rothe M; Weidner-Glunde M; Galla M; Schambach A; Cherepanov P; Schulz TF
    J Virol; 2013 Dec; 87(23):12721-36. PubMed ID: 24049186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription start regions in the human genome are favored targets for MLV integration.
    Wu X; Li Y; Crise B; Burgess SM
    Science; 2003 Jun; 300(5626):1749-51. PubMed ID: 12805549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BET-Independent Murine Leukemia Virus Integration Is Retargeted
    Nombela I; Michiels M; Van Looveren D; Marcelis L; El Ashkar S; Van Belle S; Bruggemans A; Tousseyn T; Schwaller J; Christ F; Gijsbers R; De Rijck J; Debyser Z
    Microbiol Spectr; 2022 Aug; 10(4):e0147822. PubMed ID: 35852337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine leukemia virus vector integration favors promoter regions and regional hot spots in a human T-cell line.
    Tsukahara T; Agawa H; Matsumoto S; Matsuda M; Ueno S; Yamashita Y; Yamada K; Tanaka N; Kojima K; Takeshita T
    Biochem Biophys Res Commun; 2006 Jul; 345(3):1099-107. PubMed ID: 16713998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells.
    Hematti P; Hong BK; Ferguson C; Adler R; Hanawa H; Sellers S; Holt IE; Eckfeldt CE; Sharma Y; Schmidt M; von Kalle C; Persons DA; Billings EM; Verfaillie CM; Nienhuis AW; Wolfsberg TG; Dunbar CE; Calmels B
    PLoS Biol; 2004 Dec; 2(12):e423. PubMed ID: 15550989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.
    De Rijck J; de Kogel C; Demeulemeester J; Vets S; El Ashkar S; Malani N; Bushman FD; Landuyt B; Husson SJ; Busschots K; Gijsbers R; Debyser Z
    Cell Rep; 2013 Nov; 5(4):886-94. PubMed ID: 24183673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells.
    Beard BC; Dickerson D; Beebe K; Gooch C; Fletcher J; Okbinoglu T; Miller DG; Jacobs MA; Kaul R; Kiem HP; Trobridge GD
    Mol Ther; 2007 Jul; 15(7):1356-65. PubMed ID: 17440443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroviral DNA integration--mechanism and consequences.
    Lewinski MK; Bushman FD
    Adv Genet; 2005; 55():147-81. PubMed ID: 16291214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proviruses with Long-Term Stable Expression Accumulate in Transcriptionally Active Chromatin Close to the Gene Regulatory Elements: Comparison of ASLV-, HIV- and MLV-Derived Vectors.
    Miklík D; Šenigl F; Hejnar J
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29517993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroviral integration: Site matters: Mechanisms and consequences of retroviral integration site selection.
    Demeulemeester J; De Rijck J; Gijsbers R; Debyser Z
    Bioessays; 2015 Nov; 37(11):1202-14. PubMed ID: 26293289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancers are major targets for murine leukemia virus vector integration.
    De Ravin SS; Su L; Theobald N; Choi U; Macpherson JL; Poidinger M; Symonds G; Pond SM; Ferris AL; Hughes SH; Malech HL; Wu X
    J Virol; 2014 Apr; 88(8):4504-13. PubMed ID: 24501411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disrupting MLV integrase:BET protein interaction biases integration into quiescent chromatin and delays but does not eliminate tumor activation in a MYC/Runx2 mouse model.
    Loyola L; Achuthan V; Gilroy K; Borland G; Kilbey A; Mackay N; Bell M; Hay J; Aiyer S; Fingerman D; Villanueva RA; Cameron E; Kozak CA; Engelman AN; Neil J; Roth MJ
    PLoS Pathog; 2019 Dec; 15(12):e1008154. PubMed ID: 31815961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host proteins interacting with the Moloney murine leukemia virus integrase: multiple transcriptional regulators and chromatin binding factors.
    Studamire B; Goff SP
    Retrovirology; 2008 Jun; 5():48. PubMed ID: 18554410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells.
    De Palma M; Montini E; Santoni de Sio FR; Benedicenti F; Gentile A; Medico E; Naldini L
    Blood; 2005 Mar; 105(6):2307-15. PubMed ID: 15542582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication.
    Lee SK; Nagashima K; Hu WS
    J Virol; 2005 Apr; 79(7):4159-69. PubMed ID: 15767417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.